slidebg1

International e journal of Biotechnology (IEJB) is a peer reviewed and open access journal that publishes original research articles as well as review articles in all areas of Biotechnology, Applied biotechnology, Plant biotechnology, Animal biotechnology, White/industrial biotechnology, Nano biotechnology, Nano medicine, Biomaterials, Biomaterial implants, Biotechnology applications, Bio-molecules, Cardiovascular biomaterials and Biotechnology.

International e- journal of Biotechnology provides a forum for research work directed towards microbiological and biotechnological solutions to global problems encouraging contributions from scientists from all across the globe who have an interest in tackling them. As many global issues, for example improving crop productivity, public health and waste management, have more acute consequences in the developing world, the Journal emphasizes the role of biotechnological advances, for and from developing regions.

International e- Journal of biotechnology covers all aspects of applied microbiology and biotechnology aims to publish original research papers, Mini Reviews, Short Communications, Case Reports, Image review articles, survey articles, and projects reviews in all areas dedicated to biological Research. (Single-point manuscripts that report original research with conceptual or practical advances that are of broad interest to biologists and clinicians) As a peer reviewed journal, it is positioned to promote research and educational development in the rapidly evolving field of biotechnology search around the world.


We do accept:
1) Short reports - 2-5 page papers where an author can present either an idea with theoretical background but has not yet completed the research needed for a complete paper or preliminary data.
2) Book reviews - Comments and critiques.

All manuscripts will be peer-reviewed with experts in the relevant fields and will be published within 2 months of submission if accepted. Also, systematic reviews of clinical and basic research, as well as clinical practice guidelines, are especially welcome.

All the content published with us is open and freely accessible under the guidelines of Creative Common Attribution License.